Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 16/08/2011
PIL Concerta XL 27 mg prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/08/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 21/06/2011 and displayed until 16/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 29/10/2010 and displayed until 21/06/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 06/01/2010 and displayed until 29/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 25/11/2009 and displayed until 06/01/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
Updated on 17/09/2008 and displayed until 25/11/2009
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
  • Change to side-effects
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to storage instructions
Updated on 08/09/2008 and displayed until 17/09/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
Updated on 30/07/2008 and displayed until 08/09/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 23/07/2007 and displayed until 30/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 25/06/2007 and displayed until 23/07/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 16/03/2007 and displayed until 25/06/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  methylphenidate hydrochloride